Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 25: The NEWTON-CABG CardioLink-5 Study
Author(s): Subodh Verma Added: 6 months ago
ESC Congress 2025 - NEWTON-CABG finds evolocumab with regular statin therapy did not improve vein graft patency after coronary artery bypass graft (CABG) surgery in the short-term.Dr Subodh Verma and Dr Lawrence Leiter (University of Toronto, Toronto, CA) join us to discuss findings from NEWTON-CABG CardioLink-5 (NCT03900026). The investigator-initiated multicenter, randomised, placebo-controlled… View more

Intervention
CRT 24: SYNTAX: PCI With TAXUS and CABG in Complex Coronary Disease
Author(s): Patrick W Serruys Added: 1 year ago
CRT 2024 — Prof Patrick W Serruys (National University of Ireland, Galway, US) joins us to discuss learning from the SYNTAX trial.The SYNTAX trial is a randomized controlled trial designed to evaluate the efficacy and safety of percutaneous coronary intervention (PCI) with polymer-based paclitaxel-eluting TAXUS stents versus coronary artery bypass grafting (CABG) in patients with complex coronary… View more

Intervention

Vascular Disease and Surgery
Coronary Artery Revascularization in 2025 with Dr Andrea Steely
Author(s): Andrea M Steely Added: 4 months ago
Navigate the evolving landscape of surgical coronary revascularization with Dr Andrea SteelyThis presentation, part of the Complex Cases track in Women As One's CLIMB® 2025 Skills Training Program, provides a comprehensive overview of traditional and contemporary approaches to treating coronary artery disease.Dr Steely examines traditional coronary artery bypass grafting (CABG) alongside… View more

Intervention

Prevention & Chronic Conditions
Iatrogenic LIMA Dissection during Radial Artery Graft PCI
Author(s): Andrew Vanezis Added: 2 years ago

Intervention

Prevention & Chronic Conditions
TCT 2025: 10-Year Mortality in NOBLE: PCI vs CABG for Left Main Disease
Author(s): Evald Høj Christiansen Added: 4 months ago
TCT 2025 - 10-year findings from NOBLE showed no safety concerns for percutaneous coronary intervention (PCI) compared to coronary artery bypass surgery (CABG) for the treatment of left main coronary artery (LMCA) disease.Dr Evald Høj Christiansen (Aarhus University Hospital, Aarhus, DK) joins us to share the 10-year mortality findings from the NOBLE trial, investigating PCI vs CABG in LMCA… View more

Intervention

Prevention & Chronic Conditions
Left Main Coronary Artery Intervention
Author(s): Duy Cao Phuong Le , Hoa The Bui , Quan Duy Vo Added: 1 year ago

Imaging & Diagnostics

Intervention
Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?
Author(s): Armin Arbab-Zadeh , Michelle Graham , Hector M Garcia-Garcia , et al Added: 5 months ago

Intervention

Prevention & Chronic Conditions
Bruce Rollman
Job title: Professor of Medicine, Psychiatry, and Clinical and Translational Science
Dr Bruce L Rollman's research focuses on interventions to improve the quality of care for patients with depression and anxiety who are care for in non-psychiatric settings. Dr Rollman was also Principal Investigator for the Bypassing the Blues Trial that demonstrated the effectiveness and cost-effectiveness of a nurse-led and telephone-delivered collaborative care strategy for treating depression… View more
ESC 24 Hot Line Discussion: The SWEDEGRAFT Trial
Author(s): Harriette Van Spall , Stefan James Added: 1 year ago
ESC Congress 2024 — SWEDEGRAFT does not support the routine use of no-touch vein harvest compared to the standard technique.Dr Harriette Van Spall (McMaster University, CA) sits down with principal investigator Prof Stefan James (Uppsala University, SE) to discuss results of the SWEDEGRAFT trial (NCT03501303; Uppsala University).The SWEDEGRAFT trial is a prospective, binational, multicenter, open… View more

Intervention

Vascular Disease and Surgery
Kendra J Grubb
Research Area(s) / Expertise: Job title: Surgical Director
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine. Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease. Her… View more